强势股回调，医疗器械ETF回踩5日均线

Core Viewpoint - The recent adjustments in stocks like Lide Man, Zhonghong Medical, Xiangyu Medical, and Dabo Medical have led to a nearly 1% decline in the medical device ETF (562600), indicating a short-term correction after a period of upward movement [1] Industry Summary - The A-share Shenwan Medical Device Index has experienced a continuous decline over the past four years due to policy factors such as consumable procurement and increased medical compliance requirements. However, there has been a rebound since early 2025, driven by policy easing, procurement clearance, corporate strategic transformations, and international business expansion [1] - It is anticipated that many companies will see performance and valuation recovery, with high growth expected in the second half of 2025 and 2026. Some undervalued stocks may present long-term investment opportunities [1] Company Summary - The medical device ETF (562600) serves as a convenient tool for investors to capture growth opportunities in the medical device industry. It tracks the CSI All Share Medical Device Index, which carefully selects 100 representative listed companies covering core medical fields such as medical devices, medical services, and medical information technology [1] - The medical device sector constitutes a significant 89.34% of the index, highlighting its concentrated nature and ability to accurately capture the development dividends in the medical device field [1]